136 related articles for article (PubMed ID: 7025794)
1. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
Reiss J; Wojtyła B
Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
[TBL] [Abstract][Full Text] [Related]
2. Antigenic hemagglutination inhibition test in examining of the culture supernatants of Clostridium botulinum types A, B, E, and F and some related bacterial species.
Reiss J; Wojtyła B; Lipko A
Arch Immunol Ther Exp (Warsz); 1983; 31(4):531-9. PubMed ID: 6200089
[TBL] [Abstract][Full Text] [Related]
3. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
Gimenez DF; Ciccarelli AS
Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
[No Abstract] [Full Text] [Related]
4. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
Ligieza J; Reiss J; Michalik M
Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
[TBL] [Abstract][Full Text] [Related]
5. Clostridium botulinum subtype Ba.
Giménez DF
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
[TBL] [Abstract][Full Text] [Related]
6. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
Ligieza J; Michalik M; Reiss J; Grzybowski J
Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
[TBL] [Abstract][Full Text] [Related]
7. [Use of the passive hemagglutination inhibition reaction for the purpose of determining the antigenic activity of anatoxins in vitro].
Vorontsov IV; Moshiashvili IIa; Severtsova MK; Besova SA
Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):62-6. PubMed ID: 375637
[TBL] [Abstract][Full Text] [Related]
8. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
Ligieza J; Reiss J
Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
[TBL] [Abstract][Full Text] [Related]
9. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
Oguma K; Syuto B; Iida H; Kubo S
Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
[TBL] [Abstract][Full Text] [Related]
10. Serological classification and typing of Clostridium botulinum.
Giménez DF
Dev Biol Stand; 1976; 32():175-83. PubMed ID: 793913
[TBL] [Abstract][Full Text] [Related]
11. Serological specificity of type E botulinal toxin.
Johnson HM; Smith BG; Lewis KH
Proc Soc Exp Biol Med; 1971 Jul; 137(3):973-6. PubMed ID: 4997865
[No Abstract] [Full Text] [Related]
12. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
Johnson HM; Brenner K; Angelotti R; Hall HE
J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
[TBL] [Abstract][Full Text] [Related]
13. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
Sonnenschein B
Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
[TBL] [Abstract][Full Text] [Related]
14. [The use of the indirect hemagglutination reaction for detection of botulinus toxin].
SINITSYN VA
Voen Med Zh; 1961 Oct; 10():65-7. PubMed ID: 13913382
[No Abstract] [Full Text] [Related]
15. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
Notermans S; Dufrenne J; Kozaki S
Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
[TBL] [Abstract][Full Text] [Related]
16. The antigenicity of Clostridium botulinum type C toxin administered per os.
Jansen BC; Knoetze PC; Visser F
Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
[No Abstract] [Full Text] [Related]
17. Molecular diversity of neurotoxins from Clostridium botulinum type D strains.
Moriishi K; Syuto B; Kubo S; Oguma K
Infect Immun; 1989 Sep; 57(9):2886-91. PubMed ID: 2668193
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and evaluation of a standard botulinum A antitoxin and a botulinum A test toxin].
Windler D; Patzwaldt HG; Friedemann J
Pharmazie; 1971 May; 26(5):306-8. PubMed ID: 4935133
[No Abstract] [Full Text] [Related]
19. [Properties of toxins present in the spores of the Clostridium genus with special reference to Cl. botulinum].
Rymkiewicz D
Postepy Hig Med Dosw; 1973; 27(4):407-31. PubMed ID: 4581733
[No Abstract] [Full Text] [Related]
20. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
